Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival
Sung Won Choi(University of Michigan), John E. Levine(Icahn School of Medicine at Mount Sinai), Thomas Braun(Justus-Liebig-Universität Gießen), Kenneth R. Cooke(Johns Hopkins University), Sophie Paczesny(MUSC Hollings Cancer Center), Raymond J. Hutchinson(Children's Hospital of Los Angeles), Shin Mineishi(University of Alabama at Birmingham), Carrie L. Kitko(Vanderbilt University Medical Center), Gregory A. Yanik(University of Michigan), Dawn Jones(University of Michigan), James L.M. Ferrara(Tisch Hospital), Oleg I. Krijanovski, Joel Whitfield(University of Michigan)
Cited by 141
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
|Frontiers in Immunology|2017|612
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|598
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577